Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abandon, adjournment, aldehyde, automated, broadly, cardiolipin, Cayman, conflict, conserve, deposited, DHODH, DMC, doubt, Eastern, energy, escrow, escrowed, Eurasian, exhausted, explanatory, formula, FXR, geopolitical, higher, ID, inhibitor, Inline, integrin, intravitreal, Jolla, junior, La, Medison, military, Nighthawk, PA, Page, perfluorohexyloctane, peroxidation, Philadelphia, Pontifax, quotation, redeem, redeemable, redemption, SPAC, thereto, Topline, TrkA, Union, visit, Vyleesifor, Yposmed
Removed:
accreted, acute, ahead, angela, angiotensin, ANP, asthma, atrial, bore, cardiac, cGMP, closed, coupon, cyclic, developmental, discontinued, ED, eighteen, Entresto, enzyme, fibrotic, final, floating, floor, fluid, Greenhill, guanosine, Heat, hormone, hypertrophy, India, led, LIBOR, matured, microRNA, modulating, monophosphate, muscle, native, Natrecor, neprilysin, nesiritide, neuropeptide, NPR, obstructive, physiochemical, plasma, precursor, pulmonary, rank, recombinant, relaxation, rossetti, sacubitril, secondarily, secured, shareholder, smooth, structural, tissue, valsartan, worsening
Filing tables
Filing exhibits
Related press release
Associated PTN transcripts
PTN similar filings
Filing view
External links